GV (Google Ventures) portfolio
GV (Google Ventures) has 140 portfolio companies on record at Recent Funding, with 24 investments in the last 12 months.
About this page
It is a corporate venture investor based in Mountain View, US, founded in 2009. It led 46 of the 166 rounds it joined. Its most recent investment on record is Estuary Biotherapeutics's $103M Series A round in October 2026, alongside 4BIO Capital, UPMC Enterprises, Deep Track Capital and 4 others. By category, its portfolio leans toward Health and bio (44) and Developer tools and cloud (27). It has co-invested with Kleiner Perkins, Sequoia and Greylock, most often Kleiner Perkins (19 rounds).
About GV
What GV invests in
- Health and bio · 44 · 31%
- Developer tools and cloud · 27 · 19%
- Consumer and social · 19 · 14%
- AI agents · 16 · 11%
- Fintech · 16 · 11%
- Cybersecurity · 15 · 11%
- Data and analytics · 15 · 11%
- Commerce and retail · 14 · 10%
GV recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $103M | 4BIO Capital, UPMC Enterprises, Deep Track Capital +4 | ||
| Series B+ · $310M | Jefferson Life Sciences, Novo Holdings (lead), Janus Henderson Investors +6 | ||
| round · $30M | Camino Partners, The Family, Foreground Capital +1 | ||
| Series A · $30M | .406 Ventures, Amgen, Hims +1 | ||
| Series B+ · $60M | Plural Platform, Garuda Ventures, Vertex Ventures US +3 | ||
| Series B+ · $350M | Walden Catalyst, Frontline, P7 +12 | ||
| Series B+ · $75M | Milky Way Investments (lead), ARCH Venture Partners, LoLa Capital Partners +5 | ||
| Series B+ · $85M | Wing VC, Menlo Ventures, Greylock +3 |
How GV invests
GV portfolio companies
EEstuary Biotherapeutics$103MSeries A · Oct 2026
OOMass Therapeutics$310MSeries B+ · Oct 2026
AAllara$30Mround · Oct 2026
AArboretum$30MSeries A · Oct 2026
MMetaview$60MSeries B+ · Sep 2026
SSnorkel AI$350MSeries B+ · Sep 2026
LLifeMine Therapeutics$75MSeries B+ · Aug 2026
OObsidian Security$85MSeries B+ · Aug 2026
OOblenio Bio$62MSeries B+ · Jun 2026
OOdyssey$310MSeries B+ · Jun 2026
VVerse$54MSeries B+ · Jun 2026
CContraline$92.5MSeries B+ · Jun 2026
RRecursive$650MSeries A · May 2026
SSierra$950MSeries B+ · May 2026
IIterative Health$77MSeries B+ · Apr 2026
RRicursive Intelligence$500Mround · Apr 2026
MMidi Health$100MSeries B+ · Mar 2026
SSolveAI$50MSeries A · Mar 2026
SSambaNova$350MSeries B+ · Feb 2026
IInertia$450MSeries A · Feb 2026
FFlapping Airplanes$180MSeed · Jan 2026
CCosmosSeries A · Jan 2026
Hhumans&$480MSeed · Jan 2026
SSyremis Therapeutics$165MSeries A · Dec 2025
KKick$20MSeries A · Nov 2025
OOpenEvidence$200MSeries B+ · Oct 2025
RResistant AI$25MSeries B+ · Oct 2025
HHarvey$59MSeries B+ · Oct 2025
BBlacksmith$10MSeries A · Sep 2025
TTreeline Biosciences$200MSeries A · Sep 2025
BBlue Water Autonomy$50MSeries A · Aug 2025
AAttio$52MSeries B+ · Aug 2025
CContinua$8MSeed · Aug 2025UUltromics$55MSeries B+ · Aug 2025
BBuena$58MSeries A · Jul 2025
PPostHog$70MSeries B+ · Jun 2025
MMerida Biosciences$120MSeries A · May 2025
SStackOne$20MSeries A · May 2025
LLarridin$17MSeries A · Mar 2025
BBlockaid$50MSeries B+ · Feb 2025
SSardine$70MSeries B+ · Feb 2025
RRhyGaze$86MSeries A · Jan 2025
TThings$1Mround · Jan 2025
RRoboflow$40MSeries B+ · Nov 2024
SSpeakeasy$15MSeries A · Nov 2024
LLightmatter$400MSeries B+ · Oct 2024
DDandelion Energy$40MSeries B+ · Sep 2024
UUJET$76MSeries B+ · Sep 2024
HHebbia$130MSeries B+ · Jul 2024
AAgain$43MSeries A · Jul 2024
CCardurion Pharmaceuticals$260MSeries B+ · Jul 2024
DDelphia Therapeutics$67MSeries A · May 2024
MMonzo$430MSeries B+ · Mar 2024
AAreteia Therapeutics$75MSeries A · Feb 2024
OOula Health$28MSeries B+ · Feb 2024
AAccent Therapeutics$75MSeries B+ · Jan 2024
FFlutterFlow$25.5MSeries A · Jan 2024
CComanche Biopharma$75MSeries B+ · Jan 2024
RRedpanda$100MSeries B+ · Jun 2023
TTypeface$100MSeries B+ · Jun 2023
ZZipline$330MSeries B+ · May 2023
CChronosphere$115MSeries B+ · Jan 2023
LLandis$40MSeries B+ · Oct 2022
OOmni$26.9MSeed · Aug 2022
SSingleStore$116MSeries B+ · Jul 2022
XXilis$19MSeries A · Jul 2022
MModular$30MSeed · Jun 2022
SSanas$32MSeries A · Jun 2022
MMultiverse$220MSeries B+ · Jun 2022
AAspen Neuroscience$147.5MSeries B+ · May 2022
MMirvie$60MSeries B+ · May 2022
VViz.ai$100MSeries B+ · Apr 2022
DDigits$65MSeries B+ · Mar 2022
Ddbt Labs$222MSeries B+ · Feb 2022
HHomebound$75MSeries B+ · Feb 2022
SScandit$150MSeries B+ · Feb 2022
PPecan AI$66MSeries B+ · Feb 2022
VVerana Health$150MSeries B+ · Jan 2022
CCockroach Labs$280MSeries B+ · Dec 2021
YYellowbrick Data$75MSeries B+ · Nov 2021
CCambridge Epigenetix$88MSeries B+ · Nov 2021
LLovevery$100MSeries B+ · Nov 2021
FFlock Freight$215MSeries B+ · Oct 2021
NNYM$25MSeries A · Jul 2021
IInstawork$60MSeries B+ · Jul 2021
HHeadway$70MSeries B+ · May 2021
NNanit$25MSeries B+ · Feb 2021
EEncodia$75MSeries B+ · Jan 2021
FFarmers Business Network$250MSeries B+ · Aug 2020
SSynack$52MSeries B+ · May 2020
AAlkira$22MSeries A · Apr 2020
OOrbital Insight$50MSeries B+ · Nov 2019
IImpossible Foods$300MSeries B+ · May 2019
BBrandless$240MSeries B+ · Jul 2018
CCohesity$90MSeries B+ · Apr 2017
HHivemapper$2.9MSeed · Nov 2015
DDuo Security$30MSeries B+ · Apr 2015
TTamr$16MSeries A · May 2014
NNoredink$2MSeed · Aug 2013
OOptimizely$28MSeries A · Apr 2013
MMacroscopebacker
SStackBlitzbacker
DDaydreambacker
CCounsel Healthbacker
LLaurelbacker
MMedallionbacker
TTesslbacker
CCourierbacker
DDualEntrybacker
BBasisbacker
PParadigm HealthbackerSSesamebacker
PPartifulbacker
DDriverbacker
AArmadinbacker
OObviousbacker
VVunglebacker
LLaceworkbacker
CCriblbacker
TTennrbacker
DDevoted Healthbacker
OOutdoor Voicesbacker
NNectar Socialbacker
MMokNbacker
ZZencoderbacker
GGlass Imagingbacker
CClear Labsbacker
OOwkinbacker
BBoxbeebacker
BBloom Institute of Technologybacker
PPlanGridbacker
BBionic Panda Gamesbacker
GGyftbacker
RRepublic Projectbacker
SSwing Educationbacker
HHeartThisbacker
OOsmobacker
CCreditKarmabacker
BBlavitybacker
NnChroma Biobacker
| Company | Round with GV | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $103M | $103M | Oct 16, 2026 Series A |
Health and bio |
Series B+ · $310M | $422.51M | Oct 15, 2026 Series B+ |
Insurance |
round · $30M | $40M | Oct 13, 2026 round |
Health and bio |
Series A · $30M | $30M | Oct 6, 2026 Series A |
| Series B+ · $60M | $108M | Sep 30, 2026 Series B+ | |
AI agents |
Series B+ · $350M | $585M | Sep 22, 2026 Series B+ |
Health and bio |
Series B+ · $75M | $543M | Aug 6, 2026 Series B+ |
Legal and compliance |
Series B+ · $85M | $204.5M | Aug 4, 2026 Series B+ |
Health and bio |
Series B+ · $62M | $62M | Jun 25, 2026 Series B+ |
Foundation models and research |
Series B+ · $310M | $328M | Jun 17, 2026 Series B+ |
Stablecoins |
Series B+ · $54M | $85.25M | Jun 8, 2026 Series B+ |
Health and bio |
Series B+ · $92.5M | $105.45M | Jun 2, 2026 Series B+ |
Foundation models and research |
Series A · $650M · lead | $650M | May 13, 2026 Series A |
| Series B+ · $950M · lead | $1.58B | May 4, 2026 Series B+ | |
Health and bio |
Series B+ · $77M · lead | $77M | Apr 30, 2026 Series B+ |
| round · $500M · lead | $800M | Apr 18, 2026 round | |
Health and bio |
Series B+ · $100M | $249M | Mar 17, 2026 Series B+ |
HR and recruiting |
Series A · $50M · lead | $50M | Mar 9, 2026 Series A |
AI agents |
Series B+ · $350M | $2.48B | Jul 12, 2026 Series B+ |
Climate and energy |
Series A · $450M | $450M | Feb 11, 2026 Series A |
| Seed · $180M · lead | $1.18B | Oct 21, 2026 Series A | |
Consumer and social |
Series A | undisclosed | Jan 21, 2026 Series A |
| Seed · $480M | $480M | Jan 20, 2026 Seed | |
Health and bio |
Series A · $165M | $165M | Dec 18, 2025 Series A |
Fintech |
Series A · $20M · lead | $29M | Nov 2, 2025 Series A |
Foundation models and research |
Series B+ · $200M · lead | $985M | Sep 24, 2026 Series B+ |
Fintech |
Series B+ · $25M | $44.35M | Oct 13, 2025 Series B+ |
AI agents |
Series B+ · $59M | $1.15B | Sep 21, 2026 Series B+ |
Developer tools and cloud |
Series A · $10M · lead | $125M | Oct 21, 2026 Series B+ |
Health and bio |
Series A · $200M | $461M | Sep 3, 2025 Series A |
Robotics and hardware |
Series A · $50M · lead | $64M | Aug 26, 2025 Series A |
Sales and marketing |
Series B+ · $52M · lead | $108.5M | Aug 26, 2025 Series B+ |
Consumer and social |
Seed · $8M · lead | $8M | Aug 12, 2025 Seed |
Health and bio |
Series B+ · $55M | $111M | Aug 11, 2025 Series B+ |
Real estate and construction |
Series A · $58M · lead | $58M | Jul 1, 2025 Series A |
Data and analytics |
Series B+ · $70M | $160M | Sep 29, 2025 Series B+ |
Health and bio |
Series A · $120M | $120M | May 7, 2025 Series A |
AI coding and devtools |
Series A · $20M · lead | $23.6M | May 6, 2025 Series A |
Stablecoins |
Series A · $17M | $47M | Nov 2, 2026 Series A |
Legal and compliance |
Series B+ · $50M | $117M | Nov 4, 2026 round |
AI agents |
Series B+ · $70M | $120M | May 21, 2026 Series B+ |
Health and bio |
Series A · $86M · lead | $97M | Jan 10, 2025 Series A |
Consumer and social |
round · $1M · lead | $1M | Jan 7, 2025 round |
| Series B+ · $40M · lead | $40M | Oct 4, 2025 Series B+ | |
AI coding and devtools |
Series A · $15M | $23.8M | Jul 15, 2026 round |
AI infrastructure and compute |
Series B+ · $400M | $800M | Oct 21, 2024 Series B+ |
Climate and energy |
Series B+ · $40M · lead | $143M | Sep 24, 2024 Series B+ |
Developer tools and cloud |
Series B+ · $76M | $170M | Sep 24, 2024 Series B+ |
Fintech |
Series B+ · $130M | $160M | Jul 23, 2024 Series B+ |
Climate and energy |
Series A · $43M · lead | $56.34M | Jul 17, 2024 Series A |
Health and bio |
Series B+ · $260M | $260M | Jul 16, 2024 Series B+ |
Health and bio |
Series A · $67M · lead | $67M | May 2, 2024 Series A |
Fintech |
Series B+ · $430M | $758.42M | May 8, 2024 round |
Health and bio |
Series A · $75M | $75M | Feb 13, 2024 Series A |
Health and bio |
Series B+ · $28M | $50M | Mar 22, 2024 Series B+ |
Health and bio |
Series B+ · $75M | $178M | Jan 23, 2024 Series B+ |
Media and content |
Series A · $25.5M · lead | $25.5M | Jan 11, 2024 Series A |
Health and bio |
Series B+ · $75M | $75M | Feb 26, 2025 Series B+ |
AI coding and devtools |
Series B+ · $100M | $100M | Nov 17, 2025 Series B+ |
Commerce and retail |
Series B+ · $100M | $165M | Oct 11, 2025 Series B+ |
Health and bio |
Series B+ · $330M | $1.57B | Mar 23, 2026 Series B+ |
Data and analytics |
Series B+ · $115M | $369M | Jan 10, 2023 Series B+ |
Fintech |
Series B+ · $40M · lead | $207M | Oct 19, 2022 Series B+ |
Data and analytics |
Seed · $26.9M | $235.9M | Jul 2, 2026 Series A |
Data and analytics |
Series B+ · $116M | $276M | Oct 4, 2022 Series B+ |
Health and bio |
Series A · $19M | $92M | Sep 16, 2022 Series A |
AI infrastructure and compute |
Seed · $30M · lead | $280M | Sep 28, 2025 Series B+ |
Voice and audio AI |
Series A · $32M | $102.5M | Feb 20, 2025 Series B+ |
HR and recruiting |
Series B+ · $220M | $290M | May 15, 2026 Series B+ |
Health and bio |
Series B+ · $147.5M · lead | $339M | Nov 20, 2025 Series B+ |
Health and bio |
Series B+ · $60M | $60M | May 17, 2022 Series B+ |
Health and bio |
Series B+ · $100M | $242M | Apr 7, 2022 Series B+ |
Fintech |
Series B+ · $65M | $97.5M | Mar 24, 2022 Series B+ |
Data and analytics |
Series B+ · $222M | $384.9M | Feb 24, 2022 Series B+ |
Real estate and construction |
Series B+ · $75M | $75M | Dec 15, 2025 Series B+ |
Health and bio |
Series B+ · $150M | $273.5M | Feb 9, 2022 Series B+ |
AI agents |
Series B+ · $66M | $81M | Feb 2, 2022 Series B+ |
Health and bio |
Series B+ · $150M | $202M | Apr 30, 2026 Series B+ |
AI agents |
Series B+ · $280M | $607.85M | Oct 11, 2025 Series B+ |
Data and analytics |
Series B+ · $75M | $248M | Nov 3, 2021 Series B+ |
Health and bio |
Series B+ · $88M | $93.5M | Nov 2, 2021 Series B+ |
Education |
Series B+ · $100M | $120M | Mar 25, 2026 Series B+ |
Climate and energy |
Series B+ · $215M | $388.5M | May 22, 2026 Series B+ |
AI coding and devtools |
Series A · $25M | $78M | Oct 1, 2024 Series B+ |
Health and bio |
Series B+ · $60M | $138M | Jul 5, 2023 Series B+ |
Insurance |
Series B+ · $70M | $295M | Jul 23, 2024 Series B+ |
Health and bio |
Series B+ · $25M · lead | $96M | Dec 16, 2025 Series B+ |
Health and bio |
Series B+ · $75M | $75M | Jun 26, 2024 Series A |
Lending and credit |
Series B+ · $250M | $588M | Nov 22, 2021 Series B+ |
Cybersecurity |
Series B+ · $52M | $108M | Apr 13, 2025 Seed |
AI infrastructure and compute |
Series A · $22M | $122M | Feb 3, 2025 Series B+ |
Data and analytics |
Series B+ · $50M | $61M | May 7, 2024 Series A |
Commerce and retail |
Series B+ · $300M | $1.68B | Nov 23, 2021 Series B+ |
Commerce and retail |
Series B+ · $240M | $291M | Aug 4, 2021 round |
Cybersecurity |
Series B+ · $90M · lead | $755M | May 2, 2026 Series A |
Data and analytics |
Seed · $2.9M | $52.9M | Oct 6, 2025 round |
Cybersecurity |
Series B+ · $30M | $112M | Oct 18, 2017 Series B+ |
Data and analytics |
Series A · $16M · lead | $55M | Oct 22, 2026 Series B+ |
Education |
Seed · $2M | $58M | Aug 24, 2021 Series B+ |
AI agents |
Series A · $28M | $193M | Jun 18, 2019 Series B+ |
Developer tools and cloud |
backer · source | $30M | Sep 17, 2025 Series A |
Developer tools and cloud |
backer · source | $105M | Jan 22, 2025 Series B+ |
Commerce and retail |
backer · source | $65M | Apr 2, 2026 Series A |
Health and bio |
backer · source | $36M | Oct 17, 2025 Series A |
Legal and compliance |
backer · source | $136.5M | Jun 10, 2025 Series B+ |
Health and bio |
backer · source | $43M | Aug 18, 2025 round |
AI agents |
backer · source | $125M | Jun 3, 2026 Series A |
AI agents |
backer · source | undisclosed | — |
Fintech |
backer · source | $180M | May 19, 2026 Series A |
AI agents |
backer · source | $137.6M | Feb 24, 2026 Series B+ |
Health and bio |
backer · source | $78M | Dec 4, 2025 Series B+ |
Health and bio |
backer · source | undisclosed | — |
In-person and live experiences |
backer · source | undisclosed | Nov 8, 2022 Series A |
AI agents |
backer · source | $8.5M | Oct 8, 2024 Seed |
Legal and compliance |
backer · source | $305M | Oct 2, 2026 Series B+ |
AI agents |
backer | undisclosed | — |
Developer tools and cloud |
backer | $6M | Oct 22, 2025 Seed |
Legal and compliance |
backer | $1.85B | Oct 22, 2025 Series B+ |
Cybersecurity |
backer | $350M | Oct 8, 2025 Series B+ |
Foundation models and research |
backer | $156.5M | Jan 6, 2026 Series B+ |
Insurance |
backer | $2.27B | Mar 26, 2026 Series B+ |
Commerce and retail |
backer | $42M | Jun 11, 2025 Series A |
AI agents |
backer | $30M | Jun 2, 2026 Series A |
Cybersecurity |
backer | $15M | May 29, 2026 Series A |
Consumer and social |
backer | undisclosed | Mar 23, 2026 Seed |
Commerce and retail |
backer | $20M | May 12, 2025 Series A |
Health and bio |
backer | $30M | Jul 13, 2026 Series B+ |
Health and bio |
backer | undisclosed | — |
Developer tools and cloud |
backer | undisclosed | — |
Fintech |
backer | undisclosed | — |
Developer tools and cloud |
backer | undisclosed | — |
Gaming |
backer | undisclosed | — |
Stablecoins |
backer | undisclosed | — |
Sales and marketing |
backer | undisclosed | — |
Developer tools and cloud |
backer | undisclosed | — |
Consumer and social |
backer | undisclosed | — |
Health and bio |
backer · source | $60M | Feb 4, 2026 Series B+ |
Stablecoins |
backer | undisclosed | — |
Commerce and retail |
backer | undisclosed | — |
Health and bio |
backer | $75M | Dec 12, 2024 round |
Most frequent co-investors
KKleiner Perkins19 shared rounds · last Oct 20, 2025
SSequoia15 shared rounds · last Oct 20, 2025
GGreylock13 shared rounds · last Sep 22, 2026
BBenchmark11 shared rounds · last Mar 24, 2022
IIndex Ventures9 shared rounds · last Oct 13, 2026
IInsight Partners9 shared rounds · last Sep 30, 2026
LLightspeed8 shared rounds · last Sep 22, 2026
AARCH Venture Partners8 shared rounds · last Aug 6, 2026
TTiger Global Management8 shared rounds · last May 4, 2026
NNEA8 shared rounds · last Jul 16, 2024
RRedpoint Ventures8 shared rounds · last Aug 17, 2022
MMenlo Ventures7 shared rounds · last Aug 4, 2026
Similar investors
GGaingels142 companies · 13 deals in 12 mo
MMitsubishi UFJ Capital37 companies · 10 deals in 12 mo
SSanofi Ventures22 companies · 7 deals in 12 mo
MM Ventures21 companies · 7 deals in 12 mo
PPfizer Venture Investments20 companies · 6 deals in 12 mo
NNovartis Venture Fund19 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 166 rounds on Recent Funding that name GV. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists GV, which is a subset of its real portfolio. API: /api/v1/investors/gv (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy